Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar

PHASE4CompletedINTERVENTIONAL
Enrollment

654

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 14, 2017

Study Completion Date

February 14, 2017

Conditions
Acute Pain
Interventions
DRUG

Tramadol Hydrochloride/Dexketoprofen Trometamol

DRUG

Tramadol Hydrochloride/Paracetamol

DRUG

Placebo

Trial Locations (18)

1052

Dr. Tóth Bagi Zoltán Fogászati Rendeloje, Budapest

1126

OralMed Studio Fogászati és Szájsebészeti Kft., Budapest

6725

Szegedi Tudományegyetem, Szeged

15702

Hospital Médico Quirúrgico de Conxo, A Coruña

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

37134

Azienda Ospedaliera Universitaria Integrata, Verona

41009

Hospital Universitario Virgen del Rocío, Seville

46010

Universidad de Valencia, Valencia

56126

Azienda Ospedaliero-Universitaria Pisana, Pisa

67100

Ospedale Civile San Salvatore di L'Aquila, L’Aquila

15-078

Ars-Dent, Bialystok

00-852

Gabinet Stomatologiczny Andrzej Wojtowicz AW Clinic, Warsaw

02-670

Charme Clinique Klinika Stomatologii, Warsaw

08022

Centro Medico Teknon, Barcelona

B4 6NN

Birmingham Community Healthcare NHS Foundation Trust, Birmingham

CF14 4XT

University Hospital of Wales, Cardiff

M15 6FH

University of Manchester, Manchester

ST4 6QG

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Menarini Group

INDUSTRY

NCT02777970 - Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar | Biotech Hunter | Biotech Hunter